BNP Paribas Financial Markets
INBX

BNP Paribas Financial Markets’s Inhibrx, Inc. Common Stock INBX Stock Holding History

BNP Paribas Financial Markets’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49,318
Closed -$885K – 5031
2022
Q3 		$885K Buy
+49,318
New +$889K ﹤0.01% 2585

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BNP Paribas Financial Markets's INBX Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2022, closing a stake of 49,318 shares — an estimated $885K sold.

BNP Paribas Financial Markets first reported a position in INBX in Q3 2022 and held it in 1 quarter. The position peaked at $885K in Q3 2022. 116 funds tracked by Wall St. Rank hold INBX as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 49,318 Inhibrx, Inc. Common Stock shares in Q4 2022, an estimated $885K.
  • BNP Paribas Financial Markets first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Inhibrx, Inc. Common Stock position peaked at $885K in Q3 2022.
  • 116 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.